Dinutuximab Intravenous and Posterior leukoencephalopathy syndrome
Result of checking the interaction of drug Dinutuximab Intravenous and disease Posterior leukoencephalopathy syndrome for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of dinutuximab may cause reversible posterior leukoencephalopathy syndrome (RPLS). Caution and close monitoring is advised when prescribing this agent to patients at risk of RPLS. It is recommended to administer appropriate treatment and discontinue therapy if RPLS is suspected.
Generic Name: dinutuximab
Brand Name: Unituxin
Synonyms: Dinutuximab
Dinutuximab Intravenous - zespół tylnej leukoencefalopatii 
Dinutuximab Intravenous - síndrome de leucoencefalopatia posterior 
Dinutuximab Intravenous - sindrom leukoencephalopathy posterior 
Dinutuximab Intravenous - sindrom leukoensefalopati posterior 
Dinutuximab Intravenous - sindrome da leucoencefalopatia posteriore 
Dinutuximab Intravenous - syndrome de leucoencéphalopathie postérieure 
Dinutuximab Intravenous - posteriores Leukoenzephalopathie-Syndrom 
Dinutuximab Intravenous - síndrome de leucoencefalopatía posterior 
Dinutuximab Intravenous - синдром задней лейкоэнцефалопатии 
Dinutuximab Intravenous - posterior lökoensefalopati sendromu 
Dinutuximab Intravenous - متلازمة اعتلال بيضاء الدماغ الخلفي 
Dinutuximab Intravenous - 后白质脑病综合征